Based on the annual reports, sales were KRW 58.7 billion in 2022, KRW 72.4 billion in 2023 (up 23.5% year on year), KRW 81.9 billion in 2024 (up 13.1%) and KRW 87.2 billion in 2025 (up 6.4%). Sales have risen for three consecutive years from 2023 through 2025, and 2025 was the largest year of 2022 to 2025.
Operating profit was KRW 5.26 billion in 2022, KRW 8.19 billion in 2023 (up 55.7%), KRW 8.59 billion in 2024 (up 4.9%) and KRW 8.88 billion in 2025 (up 3.3%). Growth in both sales and operating profit slowed sharply after 2023, which is the most visible change in the multi-year series.
The operating margin was 9.0% in 2022, 11.3% in 2023, 10.5% in 2024 and 10.2% in 2025, peaking in 2023. Net profit attributable to controlling shareholders was KRW 5.01 billion in 2022, KRW 10.8 billion in 2023 (up 114.7%), KRW 10.3 billion in 2024 (down 4.2%) and KRW 11.4 billion in 2025 (up 10.2%).
Net profit including non-controlling interests was reported at the same amounts for each year. Operating cash flow was KRW 2.05 billion in 2022, KRW 12.4 billion in 2023, KRW 8.9 billion in 2024 and KRW 16.2 billion in 2025, the largest of the four years.
The debt ratio climbed from 9.5% in 2022 to 11.2% in 2023, 15.8% in 2024 and 15.8% in 2025, with total liabilities of KRW 26.1 billion and total equity of KRW 165 billion at year-end 2025.
On a quarterly basis, the third quarter of 2025 posted sales of KRW 24.1 billion and operating profit of KRW 3.22 billion, followed by a fourth quarter with sales of KRW 22.6 billion (down 6.3% quarter on quarter) and operating profit of KRW 1.66 billion (down 48.5%).
The first quarter of 2026 recovered to sales of KRW 23.2 billion (up 2.8%) and operating profit of KRW 2.9 billion (up 74.9%).
Operating profit then fell to KRW 2.32 billion in the second quarter of 2026 (down 20.1%) and to KRW 1.24 billion in the third quarter (down 46.7%, or down 61.6% from a year earlier), marking two straight quarterly declines.
Net profit attributable to controlling shareholders in the third quarter of 2026 was KRW 1.03 billion, down 67.7% year on year. Profit fell far more than sales, which were down 2.0% year on year, suggesting that cost structure shifts weighed on margins.
In the third quarter of 2024, ordinary R&D expenses rose 52% year on year, showing that R&D spending can also move margins.